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Abstract 
We recently constructed a multicellular spheroid model of pancreatic tumor based on a triple 
co-culture of cancer cells, fibroblasts and endothelial cells and characterized by the presence 
of fibronectin, an important component of the tumor extracellular matrix. By combining 
cancer cells and stromal components, this model recreates in vitro the three-dimensional (3D) 
architecture of solid tumors. In this study, we used these hetero-type spheroids as a tool to 
assess the penetration of doxorubicin (used as a model drug) through the whole tumor mass 
either in a free form or loaded into polymer nanoparticles, and we investigated whether 
microscopy images, acquired by Confocal Laser Scanning Microscopy (CLSM) and Light 
Sheet Fluorescence Microscopy (LSFM), would be best to provide reliable information on 
this process. Results clearly demonstrated that CLSM was not suitable to accurately monitor 
the diffusion of small molecules such as the doxorubicin. Indeed, it only allowed to scan a 
layer of 100 µm depth and no information on deeper layers could be available because of a 
progressive loss of the fluorescence signal. On the contrary, a complete 3D tomography of the 
hetero-type multicellular tumor spheroids (MCTS) was obtained by LSFM and multi-view 
image fusion which revealed that the fluorescent molecule was able to reach the core of 
spheroids as large as 1 mm in diameter. However, no doxorubicin-loaded polymer 
nanoparticles (NPs) were detected in the spheroids, highlighting the challenge of 
nanomedicine delivery through biological barriers. Overall, the combination of hetero-type 
MCTS and LSFM allowed to carry out a highly informative microscopic assessment and 
represents a suitable approach to precisely follow up the drug penetration in tumors. 
Accordingly, it could provide useful support in the preclinical investigation and optimization 
of nanoscale systems for drug delivery to solid tumors. 
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1. Introduction  
An efficient chemotherapeutic treatment relies on the capacity of drugs, either in free form or 
loaded in nanoscale systems (i.e., nanomedicines), to move through the tumor tissue and reach 
the target cells [1]. However, the complex physiopathology of solid tumors makes the 
penetration not straightforward. It is well known that the uncontrolled growth of cancer cells 
generates a solid pressure able to compress and obstruct blood and lymphatic vessels [2] and 
that this aberrant vasculature strongly limits cancer cell accessibility to nutrients, oxygen and 
also reduces their exposure to drugs [3]. If intravenous injected drugs/nanomedicines 
succeeded to extravasate, the high interstitial fluid pressure and the thick extracellular matrix 
(ECM) would further hamper their path to the target cells. Consequently, they often 
accumulate in the perivascular space only [4, 5] and the drug concentration in the tumor does 
not reach the optimal therapeutic level [6, 7].  
Although nanomedicines can improve the drug pharmacokinetics and reduce side 
effects caused by a nonspecific systemic distribution, they frequently suffer from the 
difficulty to efficiently cross the tumor biological barriers [8-10]. It has been demonstrated 
that different physicochemical properties strongly influence the penetration of drug delivery 
systems into the tumor mass and various strategies have been proposed to maximize their 
performances [11-13]. However, the predictive in vitro assessment of the capacity of tissue 
penetration still represents one of the main difficulties in the preclinical screening of any new 
nanomedicine [6]. It is evident that such information cannot arise from 2D cell cultures. 
Indeed, in conventional uptake studies, drugs and nanomedicines are added on the top of 
cancer cells grown on flat monolayers and the only barrier they must cross to reach the 
intracellular compartment is the cell membrane. Useful data can instead be collected using 3D 
cell culture models which are more representative of the biological reality as they reproduce 
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in vitro the tumor and its microenvironment. Among them, multicellular tumor spheroids 
(MCTS) have attracted a great deal of attention thanks to their capacity to mimic key features 
of non-vascularized tumors such as the close contact among cells and their self-organization 
in layers with different proliferation rates [14, 15]. In addition, cells in spheroids secrete ECM 
proteins thus allowing to recreate a microenvironment that acts as a biological barrier able to 
interfere with the transport phenomena and to block the diffusion of drugs and NPs [11, 16]. 
However, the thickness of such 3D models represents a technical challenge making quite 
difficult the qualitative and quantitative in vitro assessment of the penetration of fluorescent 
drugs and NPs [17]. In order to overcome these issues, the penetration is often evaluated on 
spheroid slices sectioned at different depths from paraffin-embedded or frozen samples which 
are then imaged by conventional fluorescence microscopy [18-20]. However, spheroid 
sectioning is laborious and time consuming [21]. Moreover, although this strategy allows to 
obtain high quality images, it does not give a representative reconstruction of complex and 
heterogeneous 3D structures [22]. Alternatively, the penetration of fluorescent molecules into 
MCTS is largely assessed by Confocal Laser Scanning Microscopy (CLSM) through a virtual 
stack of optical sections [23-27]. In a CLSM set-up, the same lens is used for the excitation of 
dyes and the detection of the emitted signals and the pinhole system allows to remove the out-
of-focus light making possible the optical sectioning of the 3D samples [28]. However, the 
image resolution is generally restricted to depth distances of 60 - 80 μm [23, 25, 27] because 
both the excitation and emission lights, passing through the spheroid perpendicularly to the 
image plane, encounter a pronounced scattering [29]. The different refractive indices (Tyndall 
effect) and the non-uniform distribution of cells and extracellular components in the tissue 
cause wavelength-dependent phenomena of light scattering and absorption that degrade the 
quality of the fluorescent signals [30]. As a consequence, the number of emitted photons able 
to arise from the scanned sample decays exponentially with the increasing depth [31]. This 
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problem could be partially solved by the use of higher wavelengths with two- or multi-
photons microscopies [32-34]. However, because of the exposition of the whole sample to the 
excitation light during the imaging of each optical section, the above described techniques 
suffer in general from the production of important photobleaching and phototoxic effects. To 
be noted that in the case of the two /multi-photon microscopy the phenomenon is restricted to 
the focal plane in which excitation occurs [35]. 
In this context, the Light Sheet Fluorescence Microscopy (LSFM) has recently 
emerged as a technique suitable for the imaging of large biological specimens with high 
scattering properties [22, 36-39]. This approach overcomes the limitations of traditional 
microscopies and allows deep sample scan at high imaging speed with minimal photodamage 
[28, 36]. An illumination system (made of one or two illumination lenses) creates a light sheet 
of few microns thickness that scans the sample and excites only the fluorophores in the 
focused plane [40]. Since the detection lens is placed perpendicularly to the light sheet, the 
out-of-focus light is strongly reduced allowing a better definition of the scanned section (Fig. 
1a) [29, 41]. Thanks to the separation of illumination and detection pathways, only the 
detection objective is responsible for the lateral resolution [29, 42]. The optical sectioning of 
large samples is then easily obtained by moving them through the focal plane. This translation 
along the optical axis of the detector creates a z-stack of images that can be used for the 3D 
reconstruction [43, 44]. In recent years, the LSFM in combination with 3D models has been 
widely used in preclinical drug discovery to study morphological changes and toxic effects at 
the cellular level [17, 30, 44-47] and only few studies have proposed the use of this 
methodology to evaluate the penetration of drugs in simple spheroids made of only one cell 
type [48, 49]. Whether such approach would be suitable also in systems with higher 
complexity remains a matter of question.  
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In this study we investigated the performance of these imaging methodologies to assess the 
penetration of doxorubicin (Dox) and Dox-loaded polymer NPs into a hetero-type MCTS 
model of pancreatic cancer recently developed in our team [50]. This model integrates both 
the cancerous component of the pancreatic tumor (cancer cells) and cellular/acellular 
components of the microenvironment (that is, fibroblasts, endothelial cells and extracellular 
matrix) and therefore represents a valuable model capable to mimic the obstacles to diffusion. 
The advantages of the LSFM compared to the traditional CLSM in terms of deep imaging and 
isotropic resolution were largely confirmed. Overall, the results collected from the multi-view 
imaging (Fig. 1b) provide a powerful example of the LSFM application in vitro on complex 
hetero-type MCTS and strongly encourage its use since the earliest phases of preclinical 
screening of nanomedicines for tumor treatment. 
 
 
Fig. 1. Schematic illustration of (a) the LSFM detection and illuminations lenses (single 
illumination), (b) the mounting of a gel embedded-sample that allows the physical rotation for 
the multi-view imaging and (c) the LSFM in the dual-sided illumination configuration. 
Adapted with permission from ref. [41] and [39]. Copyright 2014 Springer Nature and 2012 
Wiley Periodicals 
 
 
2. Materials and methods  
2.1. Cell lines 
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Human pancreatic cancer cells (PANC-1, ATCC, France) were maintained in Dulbecco’s 
Modified Eagle Medium-high glucose (DMEM, Sigma Aldrich, France) supplemented with 
10% heat-inactivated fetal bovine serum (FBS, Gibco, France). Human lung fibroblasts 
(MRC-5, ATCC, France) were cultured in Eagle's Minimum Essential Medium (EMEM, 
Sigma Aldrich, France) supplemented with 10% heat-inactivated FBS and 1% of 200 mM L-
Glutamine solution (Sigma Aldrich, France). Human umbilical vein endothelial cells 
(HUVEC, ATCC, France) were maintained in endothelial growth medium (EGM-2) 
consisting of endothelial basal medium (EBM-2) in which supplements and growth factors 
were added according to manufacturer instruction (EGM-2 BulletKit Lonza, France). Cells 
were held in an incubator with a humid atmosphere at 37 °C with 5% CO2, used below 
passage 8 after thawing and harvested at a confluence of 70-80%. 
 
2.2. MCTS formation 
Hetero-type MCTS containing pancreatic cancer cells, fibroblasts and endothelial cells were 
constructed according to the liquid overlay technique [51] in poly(-2-hydroxyethyl 
methacrylate) (PHEMA)-coated (1.2 % (w/v)) 96 round-bottomed well plates (CELLSTAR
®
, 
Sigma Aldrich, France).  
A seeding ratio of 1:9:4 among PANC-1:MRC-5:HUVEC was used for the 
construction of both small (500:4500:2000 cells per well) and large (5000:45000:20000 cells 
per well) spheroids. As previously described [50], a fibronectin-gelatin nanometer-sized film 
was created at the MRC-5 surface before seeding according to the layer-by-layer method [52]. 
Briefly, after trypsinization, fibroblasts were suspended in 1 mL of Tris-HCl buffer (50 mM, 
pH 7.4) (Sigma Aldrich, France), centrifuged (2500 rpm, 1 min, room temperature) and then 
alternatively incubated for 1 min using a microtube rotator (VWR, France) in 1 mL of 0.04 
mg.mL
-1
 Human fibronectin or gelatin (Sigma Aldrich, France) Tris-HCl solutions (50 mM, 
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pH 7.4). Each incubation was followed by a centrifugation (2500 rpm, 1 min, room 
temperature) and a washing step with Tris-HCl buffer (1 mL, 50 mM, pH 7.4). A total of 9 
coating steps were performed. Then, fibroblasts were suspended in cell culture medium and 
used to construct the triple co-culture. Suspensions of each cell type (that is, PANC-1 cells, 
coated-MRC-5 and HUVEC) were prepared in DMEM complete medium supplemented with 
the Human vascular endothelial growth factor (VEGF, 50 ng.mL
-1
) (Thermo Fisher Scientific, 
France) and then 200 µL of their opportune mixture was transferred into each well. Automatic 
cell counting (Countess II, Thermo Fisher Scientific, France) was performed according to 
manufacturer instructions. After cell seeding, plates were centrifuged (1100 rpm, 5 min, 
20 °C) and then incubated in a humidified atmosphere with 5% CO2 at 37 °C for 4 days. 
 
2.3. Optical imaging and spheroid volume measurement 
Optical images were acquired using the AxioObserver Z1/Colibri/TIRF (Carl Zeiss, 
Germany) inverted microscope equipped with a Peltier cooled (-40 °C) CoolSnap HQ2 CCD 
camera (Photometrics,Tucson, USA) and an XL incubator thermostated at 37 °C providing 
5% CO2. By using a halogen lamp and a motorized stage in automated mode (ZenBlue 
software / high content acquisitions), transmitted light images of spheroids were collected 
directly from the PHEMA-coated plates with an EC Plan-Neofluar 2.5x/NA 0.085 dry 
objective lens.  
Through an image-processing macro, specifically created with the Image-J
®
 software, the 
minimum and major diameters of 40 spheroids were measured. Spheroid volume (V) was 
calculated according to the formula V = [(a²)*(b)]/2, in which a and b represent the minor and 
major diameter, respectively. 
 
2.4. Doxorubicin-loaded nanoparticles preparation and characterization 
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The drug-initiated method was used to grow a polyisoprene (PI) chain from an initiator 
bearing gemcitabine (Gem) [53, 54]. Then, a nitroxide exchange reaction was applied to post-
functionalize the polymer with doxorubicin (Dox) [55-57]. In this way, a gem-PI-Dox 
heterotelechelic (dual functionalized) polymer prodrug was synthesized (Fig. 7) [57]. 
Nanoparticles were formulated according to the nanoprecipitation metod [58]. In brief, 2.5 mg 
of the polymer were dissolved in 0.5 mL of tetrahydrofuran and quickly added to 1 mL of 
MilliQ water. The organic solvent was then evaporated at room temperature under vacuum 
(Buchi Rotavapor, France). The nanoparticle diameter was measured by dynamic light 
scattering (DLS) with a Nano ZS from Malvern (173° scattering angle) at a temperature of 25 
°C after 1:20 dilution in MilliQ water. The surface charge of the nanoparticles was 
investigated by zeta potential (mV) measurement at 25 °C after a 1:10 dilution with 1 mM 
NaCl by applying the Smoluchowski equation and using the same instrument. The 
morphology of the nanoparticles was observed by Transmission Electron Microscopy (TEM) 
using a JEOL JEM-1400 microscope operating at 80 kV. Images were acquired using an 
Orius camera (Gatan Inc, USA). 5 μL of diluted nanoparticle suspension (0.1 %, v/v) were 
deposited for 30 s on glow-discharged copper grids covered with formvar-carbon film. The 
excess solution was blotted off using a filter paper. Samples were then immersed for 5 min in 
a drop of uranyl acetate solution (2 wt. %) for negative staining. 
 
2.5. 3D Spheroid penetration assessment with CLSM 
Small hetero-type MCTS (500:4500:2000 cells per well) were prepared and cultured for 4 
days before incubation with doxorubicin at a concentration of 20 µM in culture medium. After 
3 h of incubation at 37 °C, MCTS were harvested, transferred in a microtube and then the 
culture medium was carefully removed. Spheroids were washed once with 200 µL of 
phosphate buffered saline (PBS, Sigma Aldrich, France) and fixed in 500 µL of 4% 
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paraformaldehyde (Roti
®
-Histofix 4%) (1 h, room temperature). Samples were imaged with 
an inverted Confocal Laser Scanning Microscope (LSM 510-Meta, Carl Zeiss, Germany) 
using a dry Plan-Apochromat 20x/NA0.75 objective lens, equipped with an argon laser (488 
nm excitation wavelength). The red fluorescence emission was collected with a 560 nm long 
pass (LP) emission filter. The pinhole was set at 1.0 Airy unit. 12-bit numerical images were 
acquired with the LSM 510 software version 3.2. 
 
2.6. 3D Spheroid penetration assessment with LSFM 
Small (500:4500:2000 cells per well) and large (5000:45000:20000 cells per well) hetero-type 
MCTS were prepared and cultured for 4 days before incubation with Dox or Dox-loaded NPs, 
(20 µM in culture medium). Small and large MCTS were harvested after 3 h and 4 h of 
incubation at 37 °C, respectively. The culture medium was carefully removed and, after one 
washing step in PBS (200 µL), spheroids were fixed in 500 µL of 4% paraformaldehyde 
(Roti
®
-Histofix 4%) (1 h, room temperature). To facilitate the post-imaging z-stack fusion, 
nuclei of large MCTS were stained. Thus, after fixation, MCTS were permeabilized with 500 
µL of 0.1% Triton X-100 (Sigma Aldrich, France) in PBS (1 h, room temperature). Then, the 
Triton solution was replaced with 200 µL of PBS and spheroids were stained at least for 24 h 
with Hoechst 33342 (NucBlue™ Reagent, Thermo Fisher Scientific, France) in the dark at 
room temperature. Spheroids were then kept in the dark with the nuclei staining solution until 
imaging. To perform the LSFM imaging, samples (small and large MCTS) were embedded in 
0.8 % low-melting agarose (Thermo Fisher Scientific, France) by using a glass cylindrical 
capillary and then images were acquired with a Lightsheet Z.1 Microscope (Carl Zeiss, 
Germany) equipped with a Plan-Apochromat 20x/NA1 water-immersion objective lens with 
left and right illumination. Red (doxorubicin) and blue (Hoechst) fluorescent signals were 
recorded after sample excitation at 488 and 405 nm, respectively. Samples were scanned 
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using the Zen 2014 SP1 Black-Edition software (Carl Zeiss, Germany) with a 575-615 nm 
band pass (BP) emission filter for Dox and a 420-470 nm BP emission filter for Hoechst. For 
small spheroids, collected optical slices were processed for the 3D reconstruction by 
maximum intensity projection (MIP) with the Image-J
®
 software. With the large MCTS, a 3D 
tomography was obtained with the Imaris Stitcher
®
 software (Bitplane AG, Zurich - 
Switzerland) by fusion of two z-stacks collected from two independent views of the same 
sample (0° and 180°). This approach allowed to make up for the low quality of the images 
acquired in the deepest part of the sample and permitted to collect relevant information from 
the different regions (Fig. 2). The Imaris
®
 software (Bitplane AG, Zurich - Switzerland) was 
used to render the 3D representation of the entire spheroid and select single optical sections. 
 
 
Fig. 2. Schematic representation of image distortion due to the spatial modification of the 
quality of the image and the compensation obtained by multi-view imaging and z-stack 
fusion. (a) Original non distorted image; (b) z-stack collected with detection at 0° (from the 
left); (c) z-stack collected with detection at 180° (from the right); (d) optical fusion of (b) and 
(c) in a single data set with better spatial resolution. Arrows indicate the axis along which the 
light is detected. Adapted with permission from ref. [59]. Copyright 2007 OSA Publishing. 
 
2.7. 2D cellular uptake assessment with CLSM 
Twelve-mm diameter confocal microscopy round coverslips (Thermo Fisher Scientific, 
France) were placed on a 24-well plate. PANC-1 cells were seeded at a density of 1.5 x 10
5
 
cells per well in complete medium. Cells were cultured for 24 h and then the medium was 
discarded and replaced with 300 µL of free Dox or Dox-loaded NPs in complete medium at a 
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concentration of 10 µM. After 90 min of incubation at 37 °C, cells were gently washed once 
with 300 µL of PBS and fixed by 20 min treatment with 4% paraformaldehyde. Then, the cell 
nuclei were stained by 20 min treatment with 200 µL of Hoechst 33342 solution in PBS. 
Finally, cells were washed twice with 300 µL of PBS and covered with a coverglass by using 
Vectashield
®
 (Vector Laboratories, USA) as mounting medium. Samples were imaged with 
an inverted Confocal Laser Scanning Microscope TCS SP8 (Leica, Germany) using a CS2 
Plan Apochromat 63x/NA 1.4 oil immersion objective lens. The instrument was equipped 
with a WLL Laser (488 nm) and a 405 nm diode for Dox and Hoechst 33342 excitation, 
respectively. The red fluorescence emission was collected with a 558–708 nm wide emission 
slits and the blue fluorescence emission was collected with a 412–466 nm wide emission slits. 
Transmission images were acquired with the 488 nm laser line and a PMT-trans detector. The 
pinhole was set at 1.0 Airy unit. 12-bit numerical images were made with the Leica SP8 LAS 
X software (Version 3.1.5; Leica, Germany). 
 
3. Results and discussion  
3.1. Penetration studies with CLSM 
Pancreatic tumor spheroids made of cancer cells and stromal components were constructed by 
seeding 500 PANC-1 cancer cells, 4500 MRC-5 fibroblasts and 2000 HUVEC cells per well 
(1:9:4 ratio) in non-adherent PHEMA-coated round-bottom well plates. As previously 
described, a 3D model integrating the three cellular components and capable to mimic the 
heterogeneity of the pancreatic tumor was obtained after 4 days of culture. At this time point, 
spheroids showed an average diameter of about 600 μm [50].  
Herein, we used this model to investigate the drug penetration by incubating spheroids with 
doxorubicin, an anticancer drug showing high DNA affinity [60] and fluorescent properties 
useful for in vitro imaging [6]. After 3 h of incubation, the penetration of Dox was firstly 
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assessed by Confocal Laser Scanning Microscopy using a z-stack of 149 focal planes and a 
step pass of 0.98 μm. Virtual slices were recorded until complete loss of the fluorescent signal 
and subsequently rendered as a maximum intensity projection (MIP) for the 3D reconstruction 
(Fig. 3a). The total scanned portion was approximately of 145 μm. The MIP clearly showed 
doxorubicin intercalation in DNA, which resulted in a strong red fluorescence in all cell 
nuclei at the spheroid surface. However, the MIP did not provide any information about the 
depth of penetration, whose appreciation required the analysis of single optical sections from 
the z-stack. The optical section taken at ~ 5 μm depth, showed Dox internalization and 
accumulation in the nuclei of cells of the external layer of the spheroid, which appeared quite 
rough and somehow irregular (Fig. 3b). Dox penetration could be observed up to 50 µm 
depth, even if a slight decrease of fluorescence was already noticed (Fig. 3c). Then, the 
continuous loss of Dox fluorescence in the deepest layers strongly reduced the imaging 
quality of the spheroid core (Fig. 3d) and at a distance of about 100 μm from the spheroid 
surface, the real degree of drug penetration could not be estimated. The absence of signal in 
the inner part of the spheroid was to ascribe to either: i) the absence of doxorubicin (that is, 
the drug was unable to reach this area) or ii) the scattering and absorption of the 3D tissue. 
These hypotheses could not be verified by CLSM, thus clearly demonstrating the limitation of 
this imaging technique in the investigation of drug diffusion into spheroids. 
 
 
Fig. 3. Confocal imaging of MCTS after incubation with doxorubicin (20 μM) for 3 h at 37 
°C. (a) Maximum intensity projection (MIP) of the z-stack; (b) optical section n° 5 at ~ 5 μm 
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depth; (c) optical section n° 50 at ~ 50 μm depth and (d) optical section n° 100 at ~ 100 μm 
depth. Scale bars: 100 μm.  
 
 
 
3.2. Penetration studies with LSFM 
Can doxorubicin penetrate through these spheroids entirely until their core? An unequivocal 
answer to this question could not be obtained by CLSM. Thus, hetero-type MCTS incubated 
with doxorubicin following the same experimental set up (i.e., concentration of 20 µM, 3 h) 
were imaged with the Carl Zeiss Lightsheet Z.1 microscope. This Selective Plane Illumination 
Microscope (SPIM) was equipped with two lenses for a double-sided illumination of the 
sample (Fig. 1c) and a light-sheet pivoting system able to create a regular exposition and to 
reduce stripe artefacts [41, 61]. The spheroid was embedded in an agarose column by filling a 
glass capillary connected to a motor that allowed the physical rotation of the sample for the 
acquisition of z-stacks from different rotation angles [30, 62]. The MIP of the whole spheroid 
(observation angle 0°) was reconstructed from 521 optical sections recorded every 0.73 μm. 
This projection (Fig. 4a), which confirmed the results obtained by CLSM (Fig. 3a), also 
clearly demonstrated the capacity of doxorubicin to penetrate into the cells and then reach the 
nuclei. While CLSM failed to assess the drug penetration in the deeper layers, herein the 
analysis of single planes highlighted the higher performance of LSFM. Indeed, the light sheet 
allowed to scan the spheroid from the surface to the core without loss of the fluorescence 
signal (Fig. 4b-d). Also, the collected images showed that the drug was able to diffuse 
uniformly in the peripheral layers (Fig. 4b) as well as in the inner ones (Fig. 4d). Once arrived 
in the centre, the spheroid was turned by 180° to also image, with high resolution, the other 
half of the sample. Such multi-view imaging is a specific feature of the LSFM and, 
interestingly, it requires only a short   acquisition time thanks to the employment of a Charge-
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Coupled Device (CCD) camera [41, 59]. 535 other optical sections with a step pass of 0.73 
μm were collected and allowed to definitively demonstrate the presence of a fluorescence 
signal in the whole spheroid and confirmed that doxorubicin was capable to diffuse through 
the entire sample (Fig. 4e-h). Overcoming the limited isotropic resolution of the conventional 
confocal technique, LSFM permitted a highly informative imaging, thus clarifying the non-
conclusive results obtained by CLSM.  
 
 
Fig. 4. LSFM imaging of MCTS after incubation with doxorubicin (20 μM, 3 h, 37 °C). 
Images from the z-stack recorded at 0°: (a) maximum intensity projection (MIP); (b) optical 
section n° 80 at ~ 58 μm depth; (c) optical section n° 150 at ~ 110 μm depth and (d) optical 
section from the middle (n° 260) at ~ 190 μm depth. Images from the z-stack recorded after 
180° rotation of the sample: (e) maximum intensity projection (MIP); (f) optical section n° 80 
at ~ 58 μm depth; (g) optical section n° 150 at ~ 110 μm depth and (h) optical section from 
the middle (n° 267) at ~ 195 μm depth. Scale bars: 100 μm  
 
To further prove the potential of the LSFM technique, we applied it to the imaging of larger 
spheroids, which in addition offered the opportunity to test the 3D tomography as post-
imaging reconstruction [59, 63] through the fusion of two z-stacks independently recorded at 
0° and 180°.  
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Hetero-type MCTS with a diameter of ~ 1 mm were constructed by keeping constant the cell 
ratio (1:9:4, PANC-1:MRC-5:HUVEC) but increasing 10 times the cell number (Fig. 5).  
 
 
Fig. 5. Representative optical image of large MCTS (5000 PANC-1 + 45000 MRC-5 + 20000 
HUVEC cells/well) at days 4 post seeding. Scale bar: 200 µm. 
 
Following spheroid incubation with doxorubicin (20 µM, 4 h), the cell nuclei were stained 
with Hoechst 33342 which allowed to display the whole 3D mass during the acquisition and 
facilitated the merging of the z-stacks during the processing. Problems related to light 
scattering and absorption are frequent with such large specimens [38, 44]. Thus, images from 
the different optical planes were collected until the first shadowing of the blue fluorescent 
signal occurred. Then, the sample rotation of 180° and the acquisition of the second z-stack 
ensured the imaging of the whole spheroid. The final fusion of the two z-stacks generated a 
single data set of 324 focal planes spaced 2.90 μm along the z-axis. Their 3D complete 
reconstruction enabled to assess the spherical volume of the sample in which the red 
fluorescence of the drug matched with all visible cell nuclei (Fig. 6a-c). The doxorubicin 
penetration in the whole spheroid was demonstrated by three different optical sections, 
recorded at depths of 113, 403 and 861 μm (Fig. 6d-i). To be noted that section 2 was 
obtained from the middle of the sample and evidenced the ability of doxorubicin to diffuse 
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deeply and reach the core of the spheroid (Fig. 6e, h). The red fluorescence signal was visible 
in the central part of the sample though the signal was shadowed and hindered the clear 
distinction of the doxorubicin in the nuclei as consequence of strong scattering phenomena. 
Overall these results confirmed the penetration capacity of small molecules into large 
spheroids and data were in agreement with the penetration depth demonstrated by other 
advanced microscopic systems [16, 49].  
 
 
Fig. 6. 3D tomography with LSFM of large MCTS after incubation with 20 μM of Dox for 4 
h at 37 °C. Overlays of blue (nuclei, Hoechst 33342 staining) and red (Dox) channels. (a) 0° 
rotation, (b) 90° rotation and (c) 180° rotation. Localization of (d) section 1 (~ 113 μm depth), 
(e) section 2 (~ 403 μm depth) and (f) section 3 (~ 861 μm depth) in relation to the entire 
spheroid. Scale bars: 200 µm. Images taken at (g) section 1, (h) section 2 and (i) section 3. 
Scale bars: 100 µm. 
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In the last decades, nanoscale drug delivery systems have been proposed to overcome the 
limitations associated with the administration of free drugs (e.g., rapid drug metabolization, 
excretion, nonspecific cell or tissue biodistribution and insurgence of resistance phenomena). 
Interestingly enough, doxorubicin has also been loaded into various nanoparticulate systems 
such as liposomes, polymer nanoparticles or micelles [64-68]. In this context, our group 
which has been working on the formulation of polymer prodrug nanoparticles since several 
years, recently developed innovative heterotelechelic polymer prodrugs comprising two 
different anticancer drugs (e.g., doxorubicin and gemcitabine) linked at the extremity [57]. By 
simple nanoprecipitation of an organic solution of these polymer prodrugs in water, spherical 
nanoparticles, with a mean diameter of ca. 100 nm, narrow size distribution, and negative 
surface charge (- 25 mV) were obtained (Fig. 7). 
 
 
 
Fig. 7. (a) Structure of heterobifunctional gemcitabine-polyisoprene-doxorubicin (Gem-PI-
Dox) polymer prodrug. (b) representative TEM image of Gem-PI-Dox nanoparticles. Scale 
bar: 1 µm. 
 
Taking advantage of the fluorescent properties of doxorubicin, we have investigated the 
ability of these NPs to diffuse through the tumor mass. The NP penetration was investigated 
following incubation (20 µM equiv. doxorubicin, 4h) with large spheroids. Spheroids were 
then imaged by SPIM and 295 optical sections from the entire spheroid were collected and 
merged. Images were recorded every 2.90 μm by two independent z-stacks at 0° and 180°. 
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Opposite to what was observed with the free drug no red fluorescence signal was detectable 
after 4h of incubation (Fig. 8) suggesting that these Dox-loaded NPs might have inferior 
penetration ability into hetero-type spheroids. The fast penetration of free doxorubicin is 
likely the result of its rapid diffusion in the ECM and in the interstitial spaces between cells, 
before being internalized and avidly bound to DNA [6, 60]. A similar behavior was likely 
hindered by the hydrophobic surface of the nanoparticles and their larger size, demonstrating 
the influence of the physico-chemical features on the diffusion capacity in this 3D tumor 
model harboring a dense ECM. This was in agreement with the previous observation of 
Kataoka and coworkers which showed that large micelles (100 nm diameter) hardly diffused 
in fibrosis-rich pancreatic tumors in vivo [69].  
 
 
Fig. 8. 3D tomography with LSFM of large MCTS after incubation with Dox-loaded NPs (20 
µM equiv. Dox, 4 h, 37 °C). Overlays of blue (nuclei, Hoechst 33342 staining) and red (Dox) 
channels. (a) 0° rotation, (b) 90° rotation, (c) 180° rotation. Scale bars: 200 µm. 
 
To be noted that, when these NPs were incubated with 2D monolayers of PANC-1 cancers 
cells, their cellular internalization was even observed at an earlier time point as shown by 
confocal microscopy (Fig. 9). However, the extent of uptake was quite poor and probably not 
enough to ensure significant penetration into the spheroid. Noteworthy is that, although low, 
this signal was detected by CLSM thanks to the larger numerical aperture compared to the 
LSFM. 
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Fig. 9. Confocal imaging of PANC-1 monolayer (2D) after incubation with Dox-loaded NPs 
(10 μM equiv. Dox) for 90 min at 37 °C. (a) Overlay of brightfield, blue (Hoechst 33342, 
nuclei) and red (Dox-loaded NPs) channels; (b) brightfield image of PANC-1 cells; (c) single 
blue channel showing cell nuclei and (d) single red channel showing internalized Dox-loaded 
NPs. Scale bars: 10 μm. 
 
Overall these data clearly confirm that a reliable prediction of the capacity of nanoparticles to 
reach the target cells and efficiently delivery their cargo requires the use of models capable to 
reproduce the complexity of the tumor tissue with multiple biological barriers. In addition, 
when moving to such models, opportune powerful imaging techniques are imperatively 
needed to strongly reduce the risk of artefactual interpretation of the experimental data, which 
is a situation that can happen when using confocal microcopy techniques only.  
 
4. Conclusions 
In this study we have shown that Light Sheet Fluorescence Microscopy, allowing to overcome 
the limitations of traditional confocal imaging techniques, offered the possibility to precisely 
discriminate the capacity of free doxorubicin and drug-loaded nanocarriers to penetrate (or 
not) in a complex 3D tumor model of pancreatic tumor. By sample imaging with a Selective 
Plane Illumination Microscope we, indeed, succeeded in monitoring the fluorescent signal in 
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the whole spheroid without loss of resolution and, thanks to complete 3D tomography of the 
MCTS, we confirmed that doxorubicin was capable to reach the spheroid core. Moreover, we 
did not observe any penetration of nanoparticles in this stroma rich-model, while they have 
easily been visualized intracellularly when incubated with cancer cells cultured in 2D. The 
strength of the LSFM for the imaging of large sample is well known but our results stress on 
the fact that the increase in complexity of in vitro models must be accompanied by an increase 
of the appropriateness of the instruments used for their analysis. To our knowledge, the results 
herein presented show for the first time a comparison on the application of these two imaging 
modalities in the analysis of drug/nanomedicine penetration. And this should strongly 
encourage the use of opportune tools to carry out a reliable preclinical in vitro screening of 
nanomedicines. 
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